"cell survival" trang 4 - tải miễn phí từ tailieunhanh
Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer

Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer
17    4    1
Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer

Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer
24    1    1
Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis

Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis
12    99    1
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: A German retrospective data analysis

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: A German retrospective data analysis
14    65    0
Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer

Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer
13    89    0
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study
11    67    0
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: A propensity score-matched analysis of real-world data

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: A propensity score-matched analysis of real-world data
10    91    0
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry
8    57    1
Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts diseasefree and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression
11    53    1
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies

Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
10    75    1
Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients

Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients
11    53    1
Clinical characteristics and outcome of pediatric patients diagnosed with Langerhans cell histiocytosis in pediatric hematology and oncology centers in Poland

Clinical characteristics and outcome of pediatric patients diagnosed with Langerhans cell histiocytosis in pediatric hematology and oncology centers in Poland
7    47    1
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma

Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
7    37    1
Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: A single-institution experience

Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: A single-institution experience
9    57    1
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: Reanalysis of the findings of a single-center prospective study

Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: Reanalysis of the findings of a single-center prospective study
8    46    1
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study

Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study
9    71    1
PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
10    26    1
Pararespiratory and paradigestive lymph node metastases in esophageal squamous cell carcinoma: Predicting survival and refining the N staging system

Pararespiratory and paradigestive lymph node metastases in esophageal squamous cell carcinoma: Predicting survival and refining the N staging system
10    1    1
Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements
12    6    1
Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: A retrospective cohort study

Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: A retrospective cohort study
10    7    1